Literature DB >> 2994232

Radiopharmaceuticals for spleen and bone marrow studies.

A G Desai, M L Thakur.   

Abstract

The spleen and bone marrow have important hematologic functions. Evaluation of bone marrow alone may be incomplete, unless the function of the spleen is studied also. In addition to hematologic functions, each organ has unique characteristics that may need to be evaluated in assessing its activity. The evaluation of the distribution of reticuloendothelial cells, through the phagocytosis of radioactive particles, provides the basis for most of the morphological and functional studies of these organs. During the past three decades, a variety of radioactive agents have been prepared and examined. Among them, colloids of 99mTc, heat-damaged 99mTc labeled RBCs, and the radionuclides of iron and indium, make possible the functional and morphological examination of the spleen and bone marrow by external scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994232     DOI: 10.1016/s0001-2998(85)80002-7

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  10 in total

1.  (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application.

Authors:  Hua Zhu; Fei Liu; Yan Zhang; Jianhua Yang; Xiaoxia Xu; Xiaoyi Guo; Teli Liu; Nan Li; Lin Zhu; Hank F Kung; Zhi Yang
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

Review 2.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

3.  Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging.

Authors:  Gianmario Sambuceti; Massimo Brignone; Cecilia Marini; Michela Massollo; Francesco Fiz; Silvia Morbelli; Ambra Buschiazzo; Cristina Campi; Roberta Piva; Anna Maria Massone; Michele Piana; Francesco Frassoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-26       Impact factor: 9.236

4.  Imaging of bone infection with labelled white blood cells: role of contemporaneous bone marrow imaging.

Authors:  A D King; A M Peters; A W Stuttle; J P Lavender
Journal:  Eur J Nucl Med       Date:  1990

5.  Copper-64 labeled liposomes for imaging bone marrow.

Authors:  Sang-Gyu Lee; Kishore Gangangari; Teja Muralidhar Kalidindi; Blesida Punzalan; Steven M Larson; Naga Vara Kishore Pillarsetty
Journal:  Nucl Med Biol       Date:  2016-08-27       Impact factor: 2.408

Review 6.  Radiological detection of bone and bone marrow metastases.

Authors:  H Jacobsson; H Göransson
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 7.  Radionuclide imaging of bone marrow disorders.

Authors:  Ali Agool; Andor W J M Glaudemans; Hendrikus H Boersma; Rudi A J O Dierckx; Edo Vellenga; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

8.  Proliferative and Glycolytic Assessment of the Whole-Body Bone Marrow Compartment.

Authors:  Mohammed Goryawala; Malek Adjoua; Seza Güleç
Journal:  Mol Imaging Radionucl Ther       Date:  2015-06-05

9.  Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14.

Authors:  Ok-Hee Kim; Geun-Hyung Kang; June Hur; Jinwook Lee; YunJae Jung; In-Sun Hong; Hookeun Lee; Seung-Yong Seo; Dae Ho Lee; Cheol Soon Lee; In-Kyu Lee; Susan Bonner-Weir; Jongsoon Lee; Young Joo Park; Hyeonjin Kim; Steven E Shoelson; Byung-Chul Oh
Journal:  Cell Death Differ       Date:  2022-01-11       Impact factor: 12.067

10.  Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.

Authors:  Chengzhong Fan; Miguel Hernandez-Pampaloni; Mohamed Houseni; Wichana Chamroonrat; Sandip Basu; Rakesh Kumar; Simin Dadparvar; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.